N-substituted hydroxyureas as urease inhibitors

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 9, 2002, Pages 1280-1282

  Uesato, Shinichi ^a   Hashimoto, Yuichiro ^a   Nishino, Masaru ^a   Nagaoka, Yasuo ^a   Kuwajima, Hiroshi ^b  

^a KANSAI UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Jack bean; N hydroxy N (m methylphenyl)urea; Urease inhibitor

Indexed keywords

ETHYLHYDROXYUREA; HYDROXYUREA; N (2 FLUOROPHENYL) N' HYDROXYUREA; N (3 FLUOROPHENYL) N' HYDROXYUREA; N (4 FLUOROPHENYL) N' HYDROXYUREA; N (BENZYLOXY) N' (2 METHOXYPHENYL)UREA; N (BENZYLOXY) N' (2 METHYLPHENYL)UREA; N (BENZYLOXY) N' (3 FLUOROPHENYL)UREA; N (BENZYLOXY) N' (3 METHOXYPHENYL)UREA; N (BENZYLOXY) N' (3 METHYLPHENYL)UREA; N (BENZYLOXY) N' (4 FLUOROPHENYL)UREA; N (BENZYLOXY) N' (4 METHOXYPHENYL)UREA; N (BENZYLOXY) N' (4 METHYLPHENYL)UREA; N (BENZYLOXY) N' (FLUOROPHENYL)UREA; N (BENZYLOXY) N' PHENYLUREA; N BUTYL N' HYDROXYUREA; N HYDROXY N' (2 METHOXYPHENYL)UREA; N HYDROXY N' (2 METHYLPHENYL)UREA; N HYDROXY N' (3 METHOXYPHENYL)UREA; N HYDROXY N' (3 METHYLPHENYL)UREA; N HYDROXY N' (3 NITROPHENYL)UREA; N HYDROXY N' (4 METHOXYPHENYL)UREA; N HYDROXY N' (4 METHYLPHENYL)UREA; N HYDROXY N' (4 NITROPHENYL)UREA; N HYDROXY N' PROPYLUREA; UNCLASSIFIED DRUG; UREASE; UREASE INHIBITOR; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ENZYME INHIBITOR;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; HELICOBACTER PYLORI; NONHUMAN; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; ENZYMOLOGY; INFRARED SPECTROPHOTOMETRY; INFRARED SPECTROSCOPY; LEGUME; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY;

CHEMISTRY, PHYSICAL; ENZYME INHIBITORS; FABACEAE; HYDROXYUREA; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR CONFORMATION; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; UREASE;

EID: 0036726522     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.1280     Document Type: Article

References (14)

1. Stearns B., Losee K. A., Bernstein J., J. Med. Chem., 6, 201 (1963).
2. Greig M. A., Neithercut W. D., Hossack M., McColl K. E., J. Clin. Pathol., 44, 157-159 (1991).
3. Brzozowski T., Sliwowski Z., Majka J., Drozdowicz D., Konturek S. J., J. Physiol. Pharmacol., 47, 137-150 (1996).
4. Blakeley R. L., Hinds J. A., Kunze H. E., Webb E. C., Zerner B., Biochemistry, 8, 1991-2000 (1969), the references cited herein.
5. Clifton G., Bryant S. R., Skinner C. G., J. Med. Chem., 13, 377-379 (1970).
6. Harmon R. E., Dabrowiak J. C., Brown D. J., Gupta S. K., Herbert M., Chitharanjan D., J. Med. Chem., 13, 577-579 (1970).
7. Ichimori K., Stuehr D. J., Atkinson R. N., King S. B., J. Med. Chem., 42, 1842-1848 (1999).
8. Ouan H.-J., Koyanagi J., Ohmori K., Uesato S., Tsuchido T., Saito S., Eur. J. Med. Chem., 37, in press (2002).
9. Van Slyke D. D., Archibald R. M., J. Biol. Chem., 154, 623-642 (1944).
10. Kobashi K., Hase J., Uehara K., Biochim. Biophys. Acta, 65, 380-383 (1962).
11. Kobayashi K., Kumaki K., Hase J., Biochim. Biophys. Acta, 227, 429-441 (1971).
12. Wilson B. D., Woodgate P. E., Henn R. W., FR Patent, 2,184,047, 1974.
13. Bodi T., Pinter I., Foldi Z., Molnar I., Racz L., HU Patent, 38,899, 1986.
14. For the preparation of NO2-substituted derivatives of 5, MeOH (2.5 ml) was added to the reaction mixture in order to promote the solubility of the isocyanates.